Microbot Medical (MBOT) Short-term Investments (2010 - 2026)

Microbot Medical has reported Short-term Investments for 13 years, with the latest figure at $806000.0 in Q1 2026.

• For the quarter ending Q1 2026, Short-term Investments fell 97.03% year-over-year to $806000.0; the trailing twelve-month figure through Mar 2026 stood at $806000.0 (down 97.03% YoY), and the FY2025 full-year result was $74.7 million, up 3069.78% from the prior year.
• Short-term Investments for Q1 2026 stood at $806000.0, down from $74.7 million in the prior quarter.
• The five-year high for Short-term Investments was $74.7 million in Q4 2025, with the low at $3000.0 in Q4 2022.
• Historically, Short-term Investments has averaged $14.3 million across 5 years, with a median of $3.9 million in 2023.
• Annual changes were most pronounced in 2022 — Short-term Investments tumbled 99.85% — and 2023, when it jumped 130466.67%.
• Microbot Medical's Short-term Investments stood at $3000.0 in 2022, then jumped by 130466.67% to $3.9 million in 2023, then plunged by 39.85% to $2.4 million in 2024, then soared by 3069.78% to $74.7 million in 2025, then sank by 98.92% to $806000.0 in 2026.
• The last three Short-term Investments figures came in at $806000.0 (Q1 2026), $74.7 million (Q4 2025), and $73.5 million (Q3 2025), per Business Quant data.